SEC Form 4 · accession 0001123292-15-001273
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julie Hambleton
Officer — EVP & Chief Medical Officer
Period of report
Sep 18, 2013
Accepted (ET)
Oct 30, 2015 · 6:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 18, 2013 | P | 800 | $14.75 | A | 800 | I | By husband's IRA |
| Common Stock | Nov 6, 2013 | P | 500 | $10.10 | A | 1,300 | I | By husband's IRA |
| Common Stock | Aug 22, 2014 | P | 400 | $10.75 | A | 1,700 | I | By husband's IRA |
| Common Stock | Sep 30, 2013 | P | 64 | $13.70 | A | 64 | I | By son's custodial account |
| Common StockF1 | holding | — | — | — | 85,919 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 179 shares granted to the reporting person by the Issuer pursuant to a company match under the Issuer's 401(k) plan.